NCT02004847
Completed
Interventional
Industry-sponsored
Blue Light for Treating Psoriasis Vulgaris
Monocenter, Randomized, Double Blinded, Intraindividual, Exploratory Study of Effectiveness and Safety of 3 Months Treatment With 2 Peak Intensities of 453nm Blue Light for the Treatment of Mild Plaque Type Psoriasis Vulgaris
| Condition studied |
Psoriasis Vulgaris |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Verena von Felbert, PD, Dr. |
| Sponsor |
Philips Electronics Nederland BV
(industry)
|
Started 2013-09-01
→
Primary completion 2014-05-01
Primary outcome
Change From Baseline (Visit 2) of the Local Psoriasis Area Severity Index (PASI) of the Target Area (High Intensity (HI) Group) as Compared to the Control Area at End of Treatment (Visit 7, Week 12).
Secondary outcome
Change From Baseline of the Local Psoriasis Area Severity Index (PASI) of the Target Area (High Intensity) as Compared to the Control Area at End of Treatment During the Attack Period (Week 4, Visit 5)
View full study on ClinicalTrials.gov